Cover Image
市場調查報告書

Drais Pharmaceuticals, Inc. - 產品平台分析

Drais Pharmaceuticals, Inc. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 259382
出版日期 內容資訊 英文 22 Pages
訂單完成後即時交付
價格
Back to Top
Drais Pharmaceuticals, Inc. - 產品平台分析 Drais Pharmaceuticals, Inc. - Product Pipeline Review - 2014
出版日期: 2014年07月31日 內容資訊: 英文 22 Pages
簡介

Drais Pharmaceuticals, Inc.是開發並商品化新治療法的製藥公司,此外也活用現行治療法以因應未滿足之醫療需求。在製成並維持開發階段化合物的投資組合之開發風險、開發階段、潛在性醫學優勢,以及商品化可能性等方面取得平衡。此外該公司也與學術機關及國際性藥學會密切合作,同時進行相關研究。

本報告提供Drais Pharmaceuticals, Inc.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Drais Pharmaceuticals, Inc.的基本資料

Drais Pharmaceuticals, Inc.概要

  • 主要資訊
  • 企業資料

Drais Pharmaceuticals, Inc.:R&D概要

  • 主要的治療範圍

Drais Pharmaceuticals, Inc.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Drais Pharmaceuticals, Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式

Drais Pharmaceuticals, Inc.:藥物簡介

  • ASP-3291
  • ASP-7147
  • ASP-7035

Drais Pharmaceuticals, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Drais Pharmaceuticals, Inc.:最近的開發平台趨勢

Drais Pharmaceuticals, Inc.:暫停中的計劃

Drais Pharmaceuticals, Inc.:總公司和子公司的所地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC05803CDB

Summary

Global Markets Direct's, 'Drais Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Drais Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Drais Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Drais Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Drais Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Drais Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

  • Evaluate Drais Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Drais Pharmaceuticals, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Drais Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Drais Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Drais Pharmaceuticals, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Drais Pharmaceuticals, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Drais Pharmaceuticals, Inc. Snapshot
    • Drais Pharmaceuticals, Inc. Overview
    • Key Information
    • Key Facts
  • Drais Pharmaceuticals, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Drais Pharmaceuticals, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Drais Pharmaceuticals, Inc. - Pipeline Products Glance
    • Drais Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
  • Drais Pharmaceuticals, Inc. - Drug Profiles
    • ASP-3291
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ASP-7147
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ASP-7035
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Drais Pharmaceuticals, Inc. - Pipeline Analysis
    • Drais Pharmaceuticals, Inc. - Pipeline Products by Target
    • Drais Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
    • Drais Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
    • Drais Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
  • Drais Pharmaceuticals, Inc. - Recent Pipeline Updates
  • Drais Pharmaceuticals, Inc. - Dormant Projects
  • Drais Pharmaceuticals, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Drais Pharmaceuticals, Inc., Key Information
  • Drais Pharmaceuticals, Inc., Key Facts
  • Drais Pharmaceuticals, Inc. - Pipeline by Indication, 2014
  • Drais Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014
  • Drais Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014
  • Drais Pharmaceuticals, Inc. - Phase II, 2014
  • Drais Pharmaceuticals, Inc. - Phase I, 2014
  • Drais Pharmaceuticals, Inc. - Pipeline by Target, 2014
  • Drais Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014
  • Drais Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014
  • Drais Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014
  • Drais Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014
  • Drais Pharmaceuticals, Inc. - Dormant Developmental Projects,2014

List of Figures

  • Drais Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2014
  • Drais Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014
  • Drais Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014
  • Drais Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2014
  • Drais Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2014
  • Drais Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2014
  • Drais Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top